AbbVie Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AbbVie Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.62B | Feb 20, 2026 |
| FY2024 | Dec 31, 2024 | $15.10B | Feb 14, 2025 |
| FY2023 | Dec 31, 2023 | $14.30B | Feb 20, 2024 |
| FY2022 | Dec 31, 2022 | $15.12B | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | $14.89B | Feb 18, 2022 |
| FY2020 | Dec 31, 2020 | $13.86B | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | $8.70B | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | $8.48B | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $8.26B | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $7.83B | Feb 21, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.16B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $56.33B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $54.32B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $58.05B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $56.20B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $45.80B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $33.27B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $32.75B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $28.22B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $25.64B | Feb 27, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $7.74B | Feb 16, 2018 |
| FY2017 | Sep 30, 2017 | $7.00B | Feb 16, 2018 |
| FY2017 | Jun 30, 2017 | $6.94B | Feb 16, 2018 |
| FY2017 | Mar 31, 2017 | $6.54B | Feb 16, 2018 |
| FY2017 | Dec 31, 2016 | $6.80B | Feb 16, 2018 |
| FY2017 | Sep 30, 2016 | $6.43B | Feb 16, 2018 |
| FY2017 | Jun 30, 2016 | $6.45B | Feb 16, 2018 |
| FY2017 | Mar 31, 2016 | $5.96B | Feb 16, 2018 |
| FY2016 | Dec 31, 2015 | $6.40B | Feb 17, 2017 |
| FY2016 | Sep 30, 2015 | $5.94B | Feb 17, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.07B | Feb 20, 2026 |
| FY2024 | Dec 31, 2024 | $10.71B | Feb 14, 2025 |
| FY2023 | Dec 31, 2023 | $8.60B | Feb 20, 2024 |
| FY2022 | Dec 31, 2022 | $10.95B | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | $10.57B | Feb 18, 2022 |
| FY2020 | Dec 31, 2020 | $9.17B | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | $6.70B | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | $6.56B | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $6.44B | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $6.13B | Feb 21, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.82B | Feb 20, 2026 |
| FY2024 | Dec 31, 2024 | ($22.00M) | Feb 14, 2025 |
| FY2023 | Dec 31, 2023 | $822.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2022 | $2.47B | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | $4.04B | Feb 18, 2022 |
| FY2020 | Dec 31, 2020 | $36.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | $2.80B | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | $1.88B | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | $741.00M | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | $2.46B | Feb 21, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.08B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $9.14B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $12.76B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $18.12B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $17.92B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $11.36B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $12.98B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $6.38B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $9.55B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $9.34B | Feb 27, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.01B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $14.75B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $12.87B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $15.26B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $12.35B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $11.30B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $6.94B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $7.40B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $6.30B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $5.88B | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.03B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $18.81B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $22.84B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $24.94B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $22.78B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $17.59B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $13.32B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $13.43B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $9.96B | Feb 21, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $974.00M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $777.00M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $695.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $787.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $798.00M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $552.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $638.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $529.00M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $479.00M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $133.96B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $135.16B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $134.71B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $138.81B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $146.53B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $150.57B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $89.12B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $59.35B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $70.79B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $66.10B | Feb 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.27B) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $3.33B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $10.36B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $17.25B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $15.41B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $13.08B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | ($8.17B) | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | ($8.45B) | Feb 21, 2020 |
| FY2019 | Dec 31, 2017 | $5.10B | Feb 21, 2020 |
| FY2019 | Dec 31, 2016 | $4.64B | Feb 21, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.64B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $34.96B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $32.29B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $32.16B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $32.38B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $33.12B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $15.60B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $15.66B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $15.79B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $15.42B | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($15.49B) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($7.90B) | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | ($1.00B) | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $4.78B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $3.13B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.06B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $4.72B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $3.37B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $5.46B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $4.38B | Feb 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.23B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $5.52B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $12.81B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $9.20B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $9.75B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $8.45B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $39.92B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $7.29B | Feb 21, 2020 |
| FY2019 | Dec 31, 2017 | $9.30B | Feb 21, 2020 |
| FY2019 | Dec 31, 2016 | $5.10B | Feb 21, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.50B | Feb 20, 2026 |
| FY2024 | Dec 31, 2024 | $66.84B | Feb 14, 2025 |
| FY2023 | Dec 31, 2023 | $59.25B | Feb 20, 2024 |
| FY2022 | Dec 31, 2022 | $63.13B | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | $75.96B | Feb 18, 2022 |
| FY2020 | Dec 31, 2020 | $84.95B | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | $67.23B | Feb 21, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 20, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Feb 14, 2025 |
| FY2023 | Dec 31, 2023 | 0 | Feb 20, 2024 |
| FY2022 | Dec 31, 2022 | 1 | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | 2 | Feb 18, 2022 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 21, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 20, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Feb 14, 2025 |
| FY2023 | Dec 31, 2023 | 0 | Feb 20, 2024 |
| FY2022 | Dec 31, 2022 | 1 | Feb 17, 2023 |
| FY2021 | Dec 31, 2021 | 2 | Feb 18, 2022 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2019 | Dec 31, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 21, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 21, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 21, 2020 |